NCT06569394View on ClinicalTrials.gov

A Study of Cannabidiol in Young Adult Cannabis Users

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 9, 2024

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Cannabis Use Disorder
Interventions
DRUG

Broad Spectrum Cannabidiol (bsCBD) 400 mg

Participants in this Arm will take 400 mg of bsCBD daily. Participants will take medication by mouth with food in the morning and evening.

DRUG

Placebo

Participants in this Arm will take a medically inert placebo. Participants will take medication by mouth with food in the morning and evening.

Trial Locations (1)

80045

RECRUITING

University of Colorado Anschutz Medical Campus, Aurora

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Colorado, Denver

OTHER